195 related articles for article (PubMed ID: 28782656)
1. Genetics and mechanisms of hepatic cystogenesis.
van de Laarschot LFM; Drenth JPH
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1491-1497. PubMed ID: 28782656
[TBL] [Abstract][Full Text] [Related]
2. Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling.
Wills ES; Te Morsche RHM; van Reeuwijk J; Horn N; Geomini I; van de Laarschot LFM; Mans DA; Ueffing M; Boldt K; Drenth JPH; Roepman R
Hum Mol Genet; 2017 Nov; 26(21):4190-4202. PubMed ID: 28973524
[TBL] [Abstract][Full Text] [Related]
3. Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease.
Mahboobipour AA; Ala M; Safdari Lord J; Yaghoobi A
Orphanet J Rare Dis; 2024 Apr; 19(1):175. PubMed ID: 38671465
[TBL] [Abstract][Full Text] [Related]
4. Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
Porath B; Gainullin VG; Cornec-Le Gall E; Dillinger EK; Heyer CM; Hopp K; Edwards ME; Madsen CD; Mauritz SR; Banks CJ; Baheti S; Reddy B; Herrero JI; Bañales JM; Hogan MC; Tasic V; Watnick TJ; Chapman AB; Vigneau C; Lavainne F; Audrézet MP; Ferec C; Le Meur Y; Torres VE; ; ; Harris PC
Am J Hum Genet; 2016 Jun; 98(6):1193-1207. PubMed ID: 27259053
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.
Wills ES; Cnossen WR; Veltman JA; Woestenenk R; Steehouwer M; Salomon J; Te Morsche RH; Huch M; Hehir-Kwa JY; Banning MJ; Pfundt R; Roepman R; Hoischen A; Drenth JP
Eur J Hum Genet; 2016 Dec; 24(12):1707-1714. PubMed ID: 27552964
[TBL] [Abstract][Full Text] [Related]
6. Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease.
Masyuk T; Masyuk A; Trussoni C; Howard B; Ding J; Huang B; LaRusso N
JHEP Rep; 2021 Oct; 3(5):100345. PubMed ID: 34568801
[TBL] [Abstract][Full Text] [Related]
7. Somatic second-hit mutations leads to polycystic liver diseases.
Banales JM; Munoz-Garrido P; Bujanda L
World J Gastroenterol; 2013 Jan; 19(1):141-3. PubMed ID: 23326178
[TBL] [Abstract][Full Text] [Related]
8. Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.
Cornec-Le Gall E; Torres VE; Harris PC
J Am Soc Nephrol; 2018 Jan; 29(1):13-23. PubMed ID: 29038287
[TBL] [Abstract][Full Text] [Related]
9. Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease.
Boerrigter MM; Duijzer R; Te Morsche RHM; Drenth JPH
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761895
[TBL] [Abstract][Full Text] [Related]
10. Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene.
Cnossen WR; Maurits JS; Salomon J; Te Morsche RH; Waanders E; Drenth JP
J Clin Lab Anal; 2016 Sep; 30(5):431-6. PubMed ID: 26365003
[TBL] [Abstract][Full Text] [Related]
11. Secondary, somatic mutations might promote cyst formation in patients with autosomal dominant polycystic liver disease.
Janssen MJ; Waanders E; Te Morsche RH; Xing R; Dijkman HB; Woudenberg J; Drenth JP
Gastroenterology; 2011 Dec; 141(6):2056-2063.e2. PubMed ID: 21856269
[TBL] [Abstract][Full Text] [Related]
12. Genetics of polycystic liver diseases.
Lee-Law PY; van de Laarschot LFM; Banales JM; Drenth JPH
Curr Opin Gastroenterol; 2019 Mar; 35(2):65-72. PubMed ID: 30652979
[TBL] [Abstract][Full Text] [Related]
13. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.
Lanktree MB; Haghighi A; Guiard E; Iliuta IA; Song X; Harris PC; Paterson AD; Pei Y
J Am Soc Nephrol; 2018 Oct; 29(10):2593-2600. PubMed ID: 30135240
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patients.
Badenas C; Torra R; Pérez-Oller L; Mallolas J; Talbot-Wright R; Torregrosa V; Darnell A
Eur J Hum Genet; 2000 Jul; 8(7):487-92. PubMed ID: 10909847
[TBL] [Abstract][Full Text] [Related]
15. Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry.
Delbarba E; Econimo L; Dordoni C; Martin E; Mazza C; Savoldi G; Alberici F; Scolari F; Izzi C
J Nephrol; 2022 Mar; 35(2):645-652. PubMed ID: 34357571
[TBL] [Abstract][Full Text] [Related]
16. Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis.
Cnossen WR; te Morsche RH; Hoischen A; Gilissen C; Chrispijn M; Venselaar H; Mehdi S; Bergmann C; Veltman JA; Drenth JP
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5343-8. PubMed ID: 24706814
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease.
Janssen MJ; Salomon J; Te Morsche RH; Drenth JP
PLoS One; 2012; 7(11):e50324. PubMed ID: 23209713
[TBL] [Abstract][Full Text] [Related]
18. Isolated polycystic liver disease genes define effectors of polycystin-1 function.
Besse W; Dong K; Choi J; Punia S; Fedeles SV; Choi M; Gallagher AR; Huang EB; Gulati A; Knight J; Mane S; Tahvanainen E; Tahvanainen P; Sanna-Cherchi S; Lifton RP; Watnick T; Pei YP; Torres VE; Somlo S
J Clin Invest; 2017 May; 127(5):1772-1785. PubMed ID: 28375157
[TBL] [Abstract][Full Text] [Related]
19. Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis.
Sierks D; Schönauer R; Friedrich A; Hantmann E; de Fallois J; Linder N; Fischer J; Herber A; Bergmann C; Berg T; Halbritter J
JHEP Rep; 2022 Nov; 4(11):100579. PubMed ID: 36246085
[TBL] [Abstract][Full Text] [Related]
20. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
